VectorBuilder has raised significant capital across multiple funding rounds, most recently securing $57.2 million in a Series C round on October 13, 2022, to expand its vector design and viral packaging platform. Founded in 2014, VectorBuilder specializes in providing biopharma outsourcing solutions, enabling researchers and companies to create custom vectors and viral constructs efficiently for gene therapy, molecular biology, and biotechnology applications.
What Is VectorBuilder and What Does It Do?
VectorBuilder, founded in 2014 by Dr. Bruce Lahn, is a leading biopharma outsourcing platform specializing in vector design and viral packaging. Headquartered in Chicago, Illinois, the company enables researchers and biotech firms to design custom vectors and package viruses such as lentivirus, adenovirus, AAV, MMLV, and piggyBac with precision and efficiency.
With a team of 201–500 employees as of July 2024, VectorBuilder streamlines the vector creation process, providing cloud-based design tools, scalable production, and support for advanced gene therapy research.
How Much Funding Has VectorBuilder Raised?
1. Series C
- Amount Raised: $57.2M
- Date: October 13, 2022
- Lead Investors: China Chengtong, Guangzhou Yuexiu Industrial Investment Fund Management
- Motivation: To scale vector design platform, expand viral packaging services, and support global biotech clients.
Total Funding Raised: $57.2 Million
Current Valuation: $1 Billion (as of july 2023)
Latest Funding Date: October 2022
Key Investors
1. China Chengtong
- Details: Investment firm supporting high-growth biotechnology and life sciences companies.
- Investment Focus Areas: Biopharma, gene therapy, molecular biology startups.
- Notable Investments: Ruqi Mobility, Hua Lien International, OOH Holdings Limited, SkyMission Group Holdings Limited..
2. Guangzhou Yuexiu Industrial Investment Fund Management
- Details: Venture and growth fund investing in technology-driven biotech and healthcare companies.
- Investment Focus Areas: Biopharma, healthcare infrastructure, life sciences technology.
- Notable Investments: Baseus, Morion NanoTech, Jland Biotech, Fengxing Milk..
Where Is VectorBuilder’s Headquarters?
VectorBuilder is headquartered in Chicago, Illinois, providing access to leading biotechnology talent, academic research partnerships, and a growing ecosystem of life sciences companies.
What’s Next for VectorBuilder?
Following its Series C funding, VectorBuilder aims to expand its vector design and viral packaging services, enhance cloud-based tools for researchers, and support scalable gene therapy development globally. With strong investor backing, VectorBuilder is positioned to remain a key player in biopharma outsourcing and gene therapy support services.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like VectorBuilder. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.
